Key facts
- Notable investors include byFounders.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Apylon
- ·The full record, as it builds
Funding rounds
No funding rounds for Apylon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Apylon
Developer of an AI-driven revenue management platform intended to optimize billing accuracy, compliance, and financial performance for healthcare providers. The company's platform applies machine learning to historical claims data and codified payer rules to build proprietary revenue management engines, offers hosted applications, autonomous billing agents, and integrated copilots that automate claim submission, auditing, clinical documentation integrity checks, and denial mitigation workflows, enabling hospitals and clinics to streamline billing operations, lower administrative costs, and increase predictable reimbursement outcomes at scale.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2025
- Employees
- 4
- Website
- apylon.co/
- Ownership
- Privately Held (backing)
Apylon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Apylon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Apylon in its N-PORT filings yet. We sweep new filings monthly.